エピソード
-
Host: Karima Benameur, MD
According to recent data, nutrition plans like the Mediterranean, DASH, and MIND diets can help patients with a variety of neurological diseases, including multiple sclerosis, stroke, and dementia. Tune in to hear Dr. Karima Benameur discuss this research and how we can counsel patients with neurological diseases about nutrition. Dr. Karima Benameur is an Associate Professor of Neurology at Emory University who presented a session on this topic at the 2024 American Academy of Neurology Annual Meeting.
-
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Lauren Treat, MD
Guest: Wendy Gaultney, MD
Children who have neurological disorders and experience pain are often not able to articulate how their pain affects them. That’s why it’s important for clinicians to understand the brain’s role in the experience of pain and how to help these patients and their families navigate their pain. Joining Dr. Charles Turck to share best practices for counseling and treating pain in children with neurological disorders are Drs. Lauren Treat and Wendy Gaultney, who presented a session on this topic at the 2024 American Academy of Neurology Annual Meeting.
-
エピソードを見逃しましたか?
-
Host: Ashley Baker, MSN, PMHNP
Guest: Stoni Johnston, APRN, MSN, PMHNP-BC
Insomnia is one of the common issues HCPs see in patients with ADHD, and narcolepsy can also have similar presentations of ADHD. So how can we accurately diagnose ADHD from a sleep disorder? Dive in as Psychiatric Nurse Practitioner Ashley Baker is joined by Stoni Johnston, Psychiatric Nurse Practitioner and Founder of Sulcata Psychiatry in Tomball, Texas.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Margaret Sibley, PhD
In the years following the COVID-19 pandemic, clinicians saw the biggest increase in patients 25 years and older seeking help for ADHD. And even though healthcare providers aren’t entirely sure where this trend came from, research shows that a lot of ADHD care went to telehealth during this time and advertisements from startup companies generating profit off of prescribing ADHD medications were hitting people on social media. So to dive into insights for providing these patients with good information, Psychiatric Nurse Practitioner Ashley Baker is joined by Dr. Margaret Sibley, Licensed Clinical Psychologist and Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine.
-
Guest: Monica Maria Diaz, M.D., M.S.
Climate change can have devastating effects on neurologic infections. One study suggested that the more population-dense urban areas are, the more likely several infections can be transmitted between humans. So what can be done to reduce this risk? Tune in with Dr. Monica Maria Diaz, Assistant Professor of Neurology at the University of North Carolina School of Medicine. This is also the topic of her session at the 2024 American Academy of Neurology Annual Meeting.
-
Host: Eliza C. Miller, MD
Stroke is one of the leading causes of death in pregnancy in the United States, underscoring the importance of knowing the causes, risks, and treatment of stroke in pregnancy and postpartum. That’s why Dr. Eliza Miller is here to share key insights from her session at the 2024 AAN Annual Meeting that focused on this exact topic. Dr. Miller is an Associate Professor of Neurology in the Division of Stroke and Cerebrovascular Disease at Columbia University.
-
Guest: Erick Tarula, MD
Many complications can occur in hospitalized neurological patients from an internal medicine standpoint. So a session from the 2024 Academy of American Neurology (AAN) Annual Meeting focused on these common issues, how they can be addressed quickly, and the role of a neurohospitalist. Dive in further with Dr. Erick Tarula, Assistant Professor in the Department of Neurology at the University of Wisconsin School of Medicine and Public Health.
-
Host: Michele Longo, MD
Medical gaslighting refers to the situation where a medical professional disregards an individual's health concerns. It most often affects patients suffering from neurological disorders like long COVID and MS, and it can be extremely damaging to the physician-patient relationship. This underscores the importance of knowing how to recognize and reduce medical gaslighting in clinical practice, which is why Dr. Michele Longo is here to discuss the “Healing Doubt: Confronting and Overcoming Medical Gaslighting” session she presented at the 2024 AAN Annual Meeting.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Nabil Ali, MD
When it comes to treating patients with schizophrenia, it’s important to remember to not have one particular medication that you stick by at all times and to consider things like their personal history and their side effects. To learn more about the treatment algorithm when managing these patients, join in with Psychiatric Nurse Practitioner Ashley Baker as she speaks with Dr. Nabil Ali, Assistant Consulting Professor in the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine in Durham, North Carolina.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Lauren Walker, OT
Occupational therapists (OT) play a crucial role in the management of schizophrenia by focusing on enhancing the patient’s ability to engage in meaningful activities and daily life tasks. Working towards a goal that a patient has by breaking it down into smaller parts is one of the ways to help a patient be successful and spark motivation. Dive in further on how OT’s assist patients through first-episode psychosis and subsequent life changes with Psychiatric Nurse Practitioner Ashley Baker as she speaks with Lauren Walker, Occupational Therapist at Northwestern Feinberg School of Medicine.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Amber Salter, PhD
In 2016, an International Advisory Committee on Clinical Trials in Multiple Sclerosis (MS) recommended that comorbidities be more clearly and consistently described in enrolled clinical trial populations for common comorbidities so we can better understand the applicability of these trial findings to those in clinical practice. And so a recent study investigated the prevalence of comorbidities in MS clinical trial populations and found that 46 percent of the participants had one or more comorbid condition. Dive further into the findings from the study that was presented at the 2023 joint ECTRIMS-ACTRIMS meeting with Ashley Baker and Dr. Amber Salter, Associate Professor of Biostatistics at the University of Texas Southwestern Medical Center.
-
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Victoria Leavitt, PhD
Disease-modifying therapies (DMTs) are an effective option for patients with multiple sclerosis (MS). In fact, a recent study presented at the 2023 joint ECTRIMS-ACTRIMS meeting in Italy found that MS patients being treated with a DMT had better cognitive function than those who were not. However, the same study also found that women are less likely than men to receive DMT treatment. Dive further into the findings with Dr. Andrew Wilner and Dr. Victoria Leavitt, Assistant Professor of Neuropsychology at Columbia University.
-
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Dejan Jakimovski, MD, PhD
Despite the fact that categorial scores like the Expanded Disability Status Scale (EDSS) and the MS Severity Scale (MSSS) are considered to be the gold standard, a recent study found that the Scripps Neurological Rating Scale (SNRS) and the Combinatorial Weight-Adjusted Disability Score (CombiWISE) may be better suited for assessing disability in patients who are severely affected by MS. Learn more about this study’s findings with Dr. Andrew Wilner and Dr. Dejan Jakimovski, a Research Assistant Professor in the Department of Neurology at the University of Buffalo who presented this research at the joint 2023 ECTRIMS-ACTRIMS meeting.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Samuel Dienel, PhD
Using postmortem brain tissue, a recent study investigated how alterations in somatostatin messenger RNA levels in the dorsolateral prefrontal cortex affect cognition among individuals with schizophrenia, bipolar disorder, and major depressive disorder. Dive into the findings with psychiatric nurse practitioner Ashley Baker and Dr. Samuel Dienel, a student in the Medical Scientist Training Program at the University of Pittsburgh.
-
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Ahmed Zayed Obeidat, MD, PhD
Guest: Lauren Beranek, BS
Polypharmacy is defined as the regular use of five or more prescribed medications, and due to their disease course, related symptoms, and side effects, patients with multiple sclerosis are at an increased risk of polypharmacy. So to hear insights on ways to identify, manage, and prevent polypharmacy, Dr. Mary Catherine Cheeley is joined by Dr. Ahmed Obeidat, Associate Professor of Neurology, and Lauren Beranek, MD candidate at the Medical College of Wisconsin.
Find a full article on their findings published in Practical Neurology.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Stanley N. Caroff, MD
Catatonia is a neuropsychiatric condition characterized by disturbances in psychomotor function, stemming from various disorders impacting brain function. And while catatonia is not specifically related to schizophrenia alone, it’s important to know how to recognize and treat schizophrenic patients with catatonic symptoms. That’s why psychiatric nurse practitioner Ashley Baker speaks with Dr. Stanley Caroff about his research focusing on the management of schizophrenia with catatonic symptoms. Dr. Caroff is an Emeritus Professor of Psychiatry at the University of Pennsylvania Perelman School of Medicine.
-
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jagan Pillai, MD, PhD
Cerebral amyloid angiopathy (CAA) is a common neurological change that frequently coexists with other pathologies like Alzheimer's disease and Lewy body dementia, which led a team of researchers to investigate the risk factors and prevalence of CAA. The study found that not only is age a risk factor for CAA, but CAA is also seen in patients with Lewy body pathology alone and in patients with both Alzheimer's disease and Lewy body pathology. Dive further into the findings with Dr. Charles Turck and Dr. Jagan Pillai, a behavioral neurologist at Cleveland Clinic Lou Ruvo Center for Brain Health.
-
Guest: Nancy Chiaravalloti, PhD
Cognitive rehabilitation in patients with multiple sclerosis started about 20 to 25 years ago when it transitioned from predominantly patients with traumatic brain injury to other patient populations including multiple sclerosis. And over that period of time, the number of studies that have examined the efficacy of cognitive rehabilitation in MS has grown substantially. However, gaps remain and further research is needed. Dive into to learn more about cognitive rehabilitation trials for MS with Dr. Nancy Chiaravalloti, Director of the Center for Neuropsychology and Neuroscience Research and the Center for Traumatic Brain Injury Research at Kessler Foundation, who also presented a session on this topic at the ACTRIMS 2024 Forum.
-
Guest: Daniel Harrison, MD
Adaptive optics is a promising tool for studying MS-related changes in the retina at a cellular level, providing valuable insights into the disease's progression and potential treatments. Dive further into this line of research with Dr. Daniel Harrison, an Associate Professor of Neurology and the Director of the Division of Multiple Sclerosis and Neuroimmunology at the University of Maryland who presented this research at the 2024 ACTRIMS Forum.
-
Host: Ashley Baker, MSN, PMHNP
Guest: Anna Shah, MD
The prevalence of multiple sclerosis seems to be increasing in patients, and the majority of those patients are diagnosed with MS around the peak family planning age. So family planning should be an integral part of comprehensive patient-centered MS care. Learn more with Psychiatric Nurse Practitioner Ashey Baker as she speaks with Dr. Anna Shah, Assistant Professor of Neurology and the Director of Neurology Outpatient Patient Safety & Experience at the University of Colorado Anschutz School of Medicine.
- もっと表示する